ClinConnect ClinConnect Logo
Search / Trial NCT02174393

Microneedling Plus the Universal Peel For Acne Scarring

Launched by ENGLEWOOD HOSPITAL AND MEDICAL CENTER · Jun 23, 2014

Trial Information

Current as of April 25, 2025

Completed

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Subject \> 18 and \< 60 years of age.
  • Subject has skin type III, IV, V, or VI as defined by the Fitzpatrick Classification Scale.
  • Subject has acne scarring as defined by the Goodman and Baron Grading System.
  • Exclusion Criteria:
  • Subject currently has moderate to severe acne on the face.
  • Subject has an active infection.
  • Subject is pregnant or lactating.
  • Subject has a history of a bleeding disorder.
  • Subject is taking an anti-coagulant.
  • Subject has a history of keloidal tendency.
  • Subject has received ablative or non-ablative laser treatments in the previous 6 months.
  • Subject has taken Accutane within the previous 3 months.

Trial Officials

Naana Boakye, MD

Principal Investigator

Englewood Hospital and Medical Center

About Englewood Hospital And Medical Center

Englewood Hospital and Medical Center is a leading healthcare institution dedicated to providing high-quality patient care and advancing medical research. Located in Englewood, New Jersey, the hospital is committed to innovative clinical practices and the development of new treatments through rigorous clinical trials. With a diverse team of experienced healthcare professionals and researchers, Englewood Hospital fosters a collaborative environment that prioritizes patient safety and ethical standards in research. The institution’s robust clinical trial program aims to explore novel therapies and improve health outcomes, contributing to the advancement of medical knowledge and the well-being of the community it serves.

Locations

Englewood Cliffs, New Jersey, United States

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials